Formation of hepatitis B virus covalently closed circular DNA: Removal of genome-linked protein

Journal of Virology

Volumn 81, Issue 12, 2007, Pages 6164-6174

  Gao, Weifan ^a   Hu, Jianming ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIRCULAR DNA; DOUBLE STRANDED DNA; RNA DIRECTED DNA POLYMERASE; VIRUS RNA;

AGAR GEL ELECTROPHORESIS; ARTICLE; CELL STRAIN HEPG2; DENSITY GRADIENT CENTRIFUGATION; DNA ISOLATION; DNA TRANSFECTION; HEPADNAVIRUS; HEPATITIS B VIRUS; NONHUMAN; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; SOUTHERN BLOTTING; VIRUS GENOME; VIRUS TRANSCRIPTION;

ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; CELL NUCLEUS; CHICKENS; DNA, CIRCULAR; DNA, VIRAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENOME, VIRAL; HEPATITIS B VIRUS; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEOCAPSID; RNA; TRANSCRIPTION, GENETIC;

AVES; DUCK HEPATITIS B VIRUS; HEPADNAVIRIDAE; HEPATITIS B VIRUS;

EID: 34249945560     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02721-06     Document Type: Article

References (81)

1. Abdelhamed, A. M., C. M. Kelley, T. G. Miller, P. A. Furman, E. E. Cable, and H. C. Isom. 2003. Comparison of anti-hepatitis B virus activities of lamivudine and clevudine by a quantitative assay. Antimicrob. Agents Chemother. 47:324-336.
2. Acs, G., M. A. Sells, R. H. Purcell, P. Price, R. Engle, M. Shapiro, and H. Popper. 1987. Hepatitis B virus produced by transfected Hep G2 cells causes hepatitis in chimpanzees. Proc. Natl. Acad. Sci. USA 84:4641-4644.
3. Anderson, A. L., K. E. Banks, M. Pontoglio, M. Yaniv, and A. McLachlan. 2005. Alpha/beta interferon differentially modulates the clearance of cytoplasmic encapsidated replication intermediates and nuclear covalently closed circular hepatitis B virus (HBV) DNA from the livers of hepatocyte nuclear factor 1α-null HBV transgenic mice. J. Virol. 79:11045-11052.
4. Bartenschlager, R., and H. Schaller. 1992. Hepadnaviral assembly is initiated by polymerase binding to the encapsidation signal in the viral RNA genome. EMBO J. 11:3413-3420.
5. Bruss, V. 1997. A short linear sequence in the pre-S domain of the large hepatitis B virus envelope protein required for virion formation. J. Virol. 71:9350-9357.
6. Chang, L. J., R. C. Hirsch, D. Ganem, and H. E. Varmus. 1990. Effects of insertional and point mutations on the functions of the duck hepatitis B virus polymerase. J. Virol. 64:5553-5558.
7. Chou, Y. C., K. S. Jeng, M. L. Chen, H. H. Liu, T. L. Liu, Y. L. Chen, Y. C. Liu, C. P. Hu, and C. Chang. 2005. Evaluation of transcriptional efficiency of hepatitis B virus covalently closed circular DNA by reverse transcription-PCR combined with the restriction enzyme digestion method. J. Virol. 79:1813-1823.
8. Colonno, R. J., E. V. Genovesi, I. Medina, L. Lamb, S. K. Durham, M. L. Huang, L. Corey, M. Littlejohn, S. Locarnini, B. C. Tennant, B. Rose, and J. M. Clark. 2001. Long-term entecavir treatment results in sustained antiviral efficacy and prolonged life span in the woodchuck model of chronic hepatitis infection. J. Infect. Dis. 184:1236-1245.
9. Connelly, J. C., and D. R. Leach. 2004. Repair of DNA covalently linked to protein. Mol. Cell 13:307-316.
10. Delaney, W. E., IV, and H. C. Isom. 1998. Hepatitis B virus replication in human HepG2 cells mediated by hepatitis B virus recombinant baculovirus. Hepatology 28:1134-1146.
11. Delaney, W. E., IV, T. G. Miller, and H. C. Isom. 1999. Use of the hepatitis B virus recombinant baculovirus-HepG2 system to study the effects of (-)-β-2′,3′-dideoxy-3′-thiacytidine on replication of hepatitis B virus and accumulation of covalently closed circular DNA. Antimicrob. Agents Chemother. 43:2017-2026.
12. Fallows, D. A., and S. P. Goff. 1995. Mutations in the epsilon sequences of human hepatitis B virus affect both RNA encapsidation and reverse transcription. J. Virol. 69:3067-3073.
13. Feitelson, M., L. Lega, J. Guo, M. Resti, M. E. Rossi, C. Azzari, B. S. Blumberg, and A. Vierucci. 1994. Pathogenesis of posttransfusion viral hepatitis in children with beta-thalassemia. Hepatology 19:558-568.
14. Feitelson, M. A., L. X. Duan, J. Guo, and B. S. Blumberg. 1995. X region deletion mutants associated with surface antigen-positive hepatitis B virus infections. Gastroenterology 108:1810-1819.
15. Feitelson, M. A., L. X. Duan, J. Guo, B. Sun, J. Woo, K. Steensma, N. Horiike, and B. S. Blumberg. 1995. X region deletion variants of hepatitis B virus in surface antigen-negative infections and non-A, non-B hepatitis. J. Infect. Dis. 172:713-722.
16. Ganem, D., and A. M. Prince. 2004. Hepatitis B virus infection - natural history and clinical consequences. N. Engl. J. Med. 350:1118- 1129.
17. Ganem, D., and R. J. Schneider. 2001. Hepadnaviridae, p. 2923-2969. In B. N. Fields and D. M. Knipe (ed.), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
18. Genovesi, E. V., L. Lamb, I. Medina, D. Taylor, M. Seifer, S. Innaimo, R. J. Colonno, D. N. Standring, and J. M. Clark. 1998. Efficacy of the carbocyclic 2′-deoxyguanosine nucleoside BMS-200475 in the woodchuck model of hepatitis B virus infection. Antimicrob. Agents Chemother. 42:3209-3217.
19. Gerlich, W., and W. S. Robinson. 1980. Hepatitis B virus contains protein covalently attached to the 5′ terminus of its complete DNA strand. Cell 21:801-809.
20. Guidotti, L. G., B. Matzke, H. Schaller, and F. V. Chisari. 1995. High-level hepatitis B virus replication in transgenic mice. J. Virol. 69:6158-6169.
21. Guidotti, L. G., R. Rochford, J. Chung, M. Shapiro, R. Purcell, and F. V. Chisari. 1999. Viral clearance without destruction of infected cells during acute HBV infection. Science 284:825-829.
22. Guo, J. T., M. Pryce, X. Wang, M. I. Barrasa, J. Hu, and C. Seeger. 2003. Conditional replication of duck hepatitis B virus in hepatoma cells. J. Virol. 77:1885-1893.
23. Hirsch, R. C., J. E. Lavine, L. J. Chang, H. E. Varmus, and D. Ganem. 1990. Polymerase gene products of hepatitis B viruses are required for genomic RNA packaging as well as for reverse transcription. Nature 344:552-555.
24. Hirt, B. 1967. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26:365-369.
25. Hu, J., D. Flores, D. Toft, X. Wang, and D. Nguyen. 2004. Requirement of heat shock protein 90 for human hepatitis B virus reverse transcriptase function. J. Virol. 78:13122-13131.
26. Hu, J., and D. Nguyen. 2004. Therapy for chronic hepatitis B: the earlier, the better? Trends Microbiol. 12:431-433.
27. Hu, J., and C. Seeger. 1996. Expression and characterization of hepadnavirus reverse transcriptases. Methods Enzymol. 275:195-208.
28. Jilbert, A. R., D. S. Miller, C. A. Scougall, H. Turnbull, and C. J. Burrell. 1996. Kinetics of duck hepatitis B virus infection following low dose virus inoculation: one virus DNA genome is infectious in neonatal ducks. Virology 226:338-345.
29. Kew, M. C., R. H. Miller, H. S. Chen, B. C. Tennant, and R. H. Purcell. 1993. Mutant woodchuck hepatitis virus genomes from virions resemble rearranged hepadnaviral integrants in hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA 90:10211-10215.
30. Ladner, S. K., M. J. Otto, C. S. Barker, K. Zaifert, G. H. Wang, J. T. Guo, C. Seeger, and R. W. King. 1997. Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication. Antimicrob. Agents Chemother. 41:1715-1720.
31. Lenhoff, R. J., and J. Summers. 1994. Coordinate regulation of replication and virus assembly by the large envelope protein of an avian hepadnavirus. J. Virol. 68:4565-4571.
32. Ling, R., and T. J. Harrison. 1997. Production of hepatitis B virus covalently closed circular DNA in transfected cells is independent of surface antigen synthesis. J. Gen. Virol. 78:1463-1467.
33. Litwin, S., E. Toll, A. R. Jilbert, and W. S. Mason. 2005. The competing roles of virus replication and hepatocyte death rates in the emergence of drug-resistant mutants: theoretical considerations. J. Clin. Virol. 34(Suppl. 1):S96-S107.
34. Locarnini, S. 2005. Molecular virology and the development of resistant mutants: implications for therapy. Semin. Liver Dis. 25(Suppl. 1):9-19.
35. Locarnini, S., and W. S. Mason. 2006. Cellular and virological mechanisms of HBV drug resistance. J. Hepatol. 44:422-431.
36. Loeb, D. L., R. C. Hirsch, and D. Ganem. 1991. Sequence-independent RNA cleavages generate the primers for plus strand DNA synthesis in hepatitis B viruses: implications for other reverse transcribing elements. EMBO J. 10:3533-3540.
37. Marion, P. L., and W. S. Robinson. 1983. Hepadna viruses: hepatitis B and related viruses. Curr. Top. Microbiol. Immunol. 105:99-121.
38. Mason, W. S., J. Cullen, G. Moraleda, J. Saputelli, C. E. Aldrich, D. S. Miller, B. Tennant, L. Frick, D. Averett, L. D. Condreay, and A. R. Jilbert. 1998. Lamivudine therapy of WHV-infected woodchucks. Virology 245:18-32.
39. Mason, W. S., M. S. Halpern, J. M. England, G. Seal, J. Egan, L. Coates, C. Aldrich, and J. Summers. 1983. Experimental transmission of duck hepatitis B virus. Virology 131:375-384.
40. Mason, W. S., A. R. Jilbert, and J. Summers. 2005. Clonal expansion of hepatocytes during chronic woodchuck hepatitis virus infection. Proc. Natl. Acad. Sci. USA 102:1139-1144.
41. Mason, W. S., G. Seal, and J. Summers. 1980. Virus of Pekin ducks with structural and biological relatedness to human hepatitis B virus. J. Virol. 36:829-836.
42. Miller, R. H., and W. S. Robinson. 1984. Hepatitis B virus DNA forms in nuclear and cytoplasmic fractions of infected human liver. Virology 137:390-399.
43. Moraleda, G., J. Saputelli, C. E. Aldrich, D. Averett, L. Condreay, and W. S. Mason. 1997. Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus. J. Virol. 71:9392-9399.
44. Murray, J. M., S. F. Wieland, R. H. Purcell, and F. V. Chisari. 2005. Dynamics of hepatitis B virus clearance in chimpanzees. Proc. Natl. Acad. Sci. USA 102:17780-17785.
45. Perlman, D., and J. Hu. 2003. Duck hepatitis B virus virion secretion requires a double-stranded DNA genome. J. Virol. 77:2287-2294.
46. Perlman, D. H., E. A. Berg, P. B. O'Connor, C. E. Costello, and J. Hu. 2005. Reverse transcription-associated dephosphorylation of hepadnavirus nucleocapsids. Proc. Natl. Acad. Sci. USA 102:9020-9025.
47. Qiao, M., C. A. Scougall, A. Duszynski, and C. J. Burrell. 1999. Kinetics of early molecular events in duck hepatitis B virus replication in primary duck hepatocytes. J. Gen. Virol. 80:2127-2135.
48. Rabe, B., A. Vlachou, N. Pante, A. Helenius, and M. Kann. 2003. Nuclear import of hepatitis B virus capsids and release of the viral genome. Proc. Natl. Acad. Sci. USA 100:9849-9854.
49. Raney, A. K., C. M. Eggers, E. F. Kline, L. G. Guidotti, M. Pontoglio, M. Yaniv, and A. McLachlan. 2001. Nuclear covalently closed circular viral genomic DNA in the liver of hepatocyte nuclear factor 1α-null hepatitis B virus transgenic mice. J. Virol. 75:2900-2911.
50. Reardon, J. T., and A. Sancar. 2006. Repair of DNA-polypeptide crosslinks by human excision nuclease. Proc. Natl. Acad. Sci. USA 103:4056-4061.
51. Robinson, W. S., D. A. Clayton, and R. L. Greenman. 1974. DNA of a human hepatitis B virus candidate. J. Virol. 14:384-391.
52. Ruiz-Opazo, N., P. R. Chakraborty, and D. A. Shafritz. 1982. Evidence for supercoiled hepatitis B virus DNA in chimpanzee liver and serum Dane particles: possible implications in persistent HBV infection. Cell 29:129-138.
53. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
54. Seeger, C., and J. Hu. 1997. Why are hepadnaviruses DNA and not RNA viruses? Trends Microbiol. 5:447-450.
55. Seeger, C., and W. S. Mason. 2000. Hepatitis B virus biology. Microbiol. Mol. Biol. Rev. 64:51-68.
56. Sprinzl, M. F., H. Oberwinkler, H. Schaller, and U. Protzer. 2001. Transfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: crossing the species barrier. J. Virol. 75:5108-5118.
57. Staprans, S., D. D. Loeb, and D. Ganem. 1991. Mutations affecting hepadnavirus plus-strand DNA synthesis dissociate primer cleavage from translocation and reveal the origin of linear viral DNA. J. Virol. 65:1255-1262.
58. Summers, J., A. R. Jilbert, W. Yang, C. E. Aldrich, J. Saputelli, S. Litwin, E. Toll, and W. S. Mason. 2003. Hepatocyte turnover during resolution of a transient hepadnaviral infection. Proc. Natl. Acad. Sci. USA 100:11652-11659.
59. Summers, J., and W. S. Mason. 1982. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 29:403-415.
60. Summers, J., A. O'Connell, and I. Millman. 1975. Genome of hepatitis B virus: restriction enzyme cleavage and structure of DNA extracted from Dane particles. Proc. Natl. Acad. Sci. USA 72:4597-4601.
61. Summers, J., P. M. Smith, and A. L. Horwich. 1990. Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification. J. Virol. 64:2819-2824.
62. Summers, J., P. M. Smith, M. J. Huang, and M. S. Yu. 1991. Morphogenetic and regulatory effects of mutations in the envelope proteins of an avian hepadnavirus. J. Virol. 65:1310-1317.
63. Summers, J., J. M. Smolec, and R. Snyder. 1978. A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks. Proc. Natl. Acad. Sci. USA 75:4533-4537.
64. Sung, J. J., M. L. Wong, S. Bowden, C. T. Liew, A. Y. Hui, V. W. Wong, N. W. Leung, S. Locarnini, and H. L. Chan. 2005. Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy. Gastroenterology 128:1890-1897.
65. Tuttleman, J. S., C. Pourcel, and J. Summers. 1986. Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell 47:451-460.
66. Wang, G. H., and C. Seeger. 1992. The reverse transcriptase of hepatitis B virus acts as a protein primer for viral DNA synthesis. Cell 71:663-670.
67. Wang, X., N. Grammatikakis, and J. Hu. 2002. Role of p50/CDC37 in hepadnavirus assembly and replication. J. Biol. Chem. 277:24361-24367.
68. Weber, M., V. Bronsema, H. Bartos, A. Bosserhoff, R. Bartenschlager, and H. Schaller. 1994. Hepadnavirus P protein utilizes a tyrosine residue in the TP domain to prime reverse transcription. J. Virol. 68:2994-2999.
69. Werle-Lapostolle, B., S. Bowden, S. Locarnini, K. Wursthorn, J. Petersen, G. Lau, C. Trepo, P. Marcellin, Z. Goodman, W. E. Delaney IV, S. Xiong, C. L. Brosgart, S. S. Chen, C. S. Gibbs, and F. Zoulim. 2004. Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology 126:1750- 1758.
70. Wieland, S. F., H. C. Spangenberg, R. Thimme, R. H. Purcell, and F. V. Chisari. 2004. Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees. Proc. Natl. Acad. Sci. USA 101:2129-2134.
71. Wu, T. T., L. Coates, C. E. Aldrich, J. Summers, and W. S. Mason. 1990. In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway. Virology 175:255-261.
72. Wu, T.-T., L. D. Condreay, L. Coates, C. Aldrich, and W. Mason. 1991. Evidence that less-than-full-length pol gene products are functional in hepadnavirus DNA synthesis. J. Virol. 65:2155-2163.
73. Yang, W., W. S. Mason, and J. Summers. 1996. Covalently closed circular viral DNA formed from two types of linear DNA in woodchuck hepatitis virus-infected liver. J. Virol. 70:4567-4575.
74. Yang, W., and J. Summers. 1995. Illegitimate replication of linear hepadnavirus DNA through nonhomologous recombination. J. Virol. 69:4029-4036.
75. Yang, W., and J. Summers. 1998. Infection of ducklings with virus particles containing linear double-stranded duck hepatitis B virus DNA: illegitimate replication and reversion. J. Virol. 72:8710-8717.
76. Zhang, Y. Y., D. P. Theele, and J. Summers. 2005. Age-related differences in amplification of covalently closed circular DNA at early times after duck hepatitis B virus infection of ducks. J. Virol. 79:9896-9903.
77. Zhang, Y. Y., B. H. Zhang, D. Theele, S. Litwin, E. Toll, and J. Summers. 2003. Single-cell analysis of covalently closed circular DNA copy numbers in a hepadnavirus-infected liver. Proc. Natl. Acad. Sci. USA 100:12372-12377.
78. Zhou, T., H. Guo, J. T. Guo, A. Cuconati, A. Mehta, and T. M. Block. 2006. Hepatitis B virus e antigen production is dependent upon covalently closed circular (ccc) DNA in HepAD38 cell cultures and may serve as a cccDNA surrogate in antiviral screening assays. Antivir. Res. 72:116-124.
79. Zhu, Y., T. Yamamoto, J. Cullen, J. Saputelli, C. E. Aldrich, D. S. Miller, S. Litwin, P. A. Furman, A. R. Jilbert, and W. S. Mason. 2001. Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis. J. Virol. 75:311-322.
80. Zoulim, F. 2005. Combination of nucleoside analogues in the treatment of chronic hepatitis B virus infection: lesson from experimental models. J. Antimicrob. Chemother. 55:608-611.
81. Zoulim, F., and C. Seeger. 1994. Reverse transcription in hepatitis B viruses is primed by a tyrosine residue of the polymerase. J. Virol. 68:6-13.